Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Rosenberg EC, Patra PH, Whalley BJ.

Epilepsy Behav. 2017 Feb 9. pii: S1525-5050(16)30531-5. doi: 10.1016/j.yebeh.2016.11.006. [Epub ahead of print] Review.

PMID:
28190698
2.

Treatment issues for children with epilepsy transitioning to adult care.

Nabbout R, Camfield CS, Andrade DM, Arzimanoglou A, Chiron C, Cramer JA, French JA, Kossoff E, Mula M, Camfield PR.

Epilepsy Behav. 2017 Feb 7. pii: S1525-5050(16)30631-X. doi: 10.1016/j.yebeh.2016.11.008. [Epub ahead of print] Review.

PMID:
28188045
3.

A case for cannabidiol in Wolf-Hirschhorn syndrome seizure management.

Ho KS, Wassman ER.

Am J Med Genet A. 2017 Feb;173(2):324-326. doi: 10.1002/ajmg.a.37979.

PMID:
28102593
4.

Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.

Treat L, Chapman KE, Colborn KL, Knupp KG.

Epilepsia. 2017 Jan;58(1):123-127. doi: 10.1111/epi.13617.

PMID:
27859038
5.

Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.

Hess EJ, Moody KA, Geffrey AL, Pollack SF, Skirvin LA, Bruno PL, Paolini JL, Thiele EA.

Epilepsia. 2016 Oct;57(10):1617-1624. doi: 10.1111/epi.13499.

PMID:
27696387
6.

Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.

Gofshteyn JS, Wilfong A, Devinsky O, Bluvstein J, Charuta J, Ciliberto MA, Laux L, Marsh ED.

J Child Neurol. 2016 Sep 21. pii: 0883073816669450. [Epub ahead of print]

PMID:
27655472
7.

From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?

Lippiello P, Balestrini S, Leo A, Coppola A, Citraro R, Elia M, Russo E, De Sarro G.

Curr Pharm Des. 2016;22(42):6426-6433. doi: 10.2174/1381612822666160831122722.

PMID:
27587196
8.

Medical Marijuana for Epilepsy?

Kolikonda MK, Srinivasan K, Enja M, Sagi V, Lippmann S.

Innov Clin Neurosci. 2016 Apr 1;13(3-4):23-6.

9.

Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.

Fasinu PS, Phillips S, ElSohly MA, Walker LA.

Pharmacotherapy. 2016 Jul;36(7):781-96. doi: 10.1002/phar.1780. Review.

PMID:
27285147
10.

Treatment of Dravet Syndrome.

Wirrell EC.

Can J Neurol Sci. 2016 Jun;43 Suppl 3:S13-8. doi: 10.1017/cjn.2016.249. Review.

PMID:
27264138
11.

Endocannabinoid System: A Multi-Facet Therapeutic Target.

Kaur R, Ambwani SR, Singh S.

Curr Clin Pharmacol. 2016;11(2):110-7. Review.

PMID:
27086601
12.

Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome.

Rubio M, Valdeolivas S, Piscitelli F, Verde R, Satta V, Barroso E, Montolio M, Aras LM, Di Marzo V, Sagredo O, Fernández-Ruiz J.

Pharmacol Res Perspect. 2016 Mar 5;4(2):e00220. doi: 10.1002/prp2.220.

13.

Cannabidiol and epilepsy: Rationale and therapeutic potential.

Leo A, Russo E, Elia M.

Pharmacol Res. 2016 May;107:85-92. doi: 10.1016/j.phrs.2016.03.005. Review.

PMID:
26976797
14.

CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.

Tzadok M, Uliel-Siboni S, Linder I, Kramer U, Epstein O, Menascu S, Nissenkorn A, Yosef OB, Hyman E, Granot D, Dor M, Lerman-Sagie T, Ben-Zeev B.

Seizure. 2016 Feb;35:41-4. doi: 10.1016/j.seizure.2016.01.004.

15.

The Pharmacological Basis of Cannabis Therapy for Epilepsy.

Reddy DS, Golub VM.

J Pharmacol Exp Ther. 2016 Apr;357(1):45-55. doi: 10.1124/jpet.115.230151. Review.

PMID:
26787773
16.

Cannabidiol for epilepsy: trying to see through the haze.

Detyniecki K, Hirsch LJ.

Lancet Neurol. 2016 Mar;15(3):235-7. doi: 10.1016/S1474-4422(16)00002-8. No abstract available.

PMID:
26776916
17.

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR.

Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Erratum in: Lancet Neurol. 2016 Apr;15(4):352.

18.

Cannabis and Endocannabinoid Signaling in Epilepsy.

Katona I.

Handb Exp Pharmacol. 2015;231:285-316. doi: 10.1007/978-3-319-20825-1_10. Review.

PMID:
26408165
19.

Drug development: The treasure chest.

Owens B.

Nature. 2015 Sep 24;525(7570):S6-8. doi: 10.1038/525S6a. No abstract available.

PMID:
26398738
20.
Items per page

Supplemental Content

Loading ...
Support Center